Last updated: June 25, 2026
Suppliers for Sodium Phenylacetate and Sodium Benzoate: Who Produces the Active Salts, Intermediates, and Common Compendial Sources?
Key points: Sodium phenylacetate and sodium benzoate are widely sourced commodity-like chemicals and pharmaceutical excipient actives. Supplier breadth is broad across bulk chemical manufacturers, specialty chemical makers, and compendial API/excipient distributors. Core risk for procurement is not “availability,” but grade fit (FCC/food vs USP/NF vs reagent vs pharmaceutical), trace-specs (assay, residual solvents, impurities), and salt form consistency (anhydrous vs hydrated, particle size, PSD for blends).
What suppliers make sodium phenylacetate for pharmaceutical use?
Sodium phenylacetate is commonly supplied either as (1) direct bulk chemical from specialty or bulk-chemical plants, or (2) pharmaceutical-grade material distributed by ingredient wholesalers that source from multiple upstream manufacturers. The downstream pharmaceutical market typically tightens specs to USP/NF-style requirements, including assay, alkalinity limits, and impurity profiles.
Typical supplier categories
- Bulk chemical manufacturers: produce sodium phenylacetate at scale for industrial, food/pharma-adjacent uses.
- Specialty chemical manufacturers: focus on tighter specs and documentation packages.
- Pharmaceutical ingredient distributors: rebrand and distribute from upstream manufacturers; key advantage is CoA discipline and batch traceability.
- Compendial/food-grade ingredient suppliers: if formulation uses allow, some tend to carry higher volume and stable lead times.
Procurement-grade checkpoints that determine “pharmaceutical acceptability”
- Assay purity (target range per internal spec; commonly high purity).
- Impurity panel (benzoate-like impurities, phenylacetate esters, aromatic byproducts).
- Water content and polymorph/hydrate control for salt handling and formulation.
- Particle size if blending with powders.
- Solvent residuals if produced via solvent routes.
- Documentation: GMP/DMF/CoA format and stability package.
What companies supply sodium benzoate for pharmaceutical and food/pharma uses?
Sodium benzoate is a widely traded preservative salt and is also used in pharmaceutical formulations and as a preservative in certain oral liquids and topical preparations. Supplier diversity is high, and the market has multiple standard supply chains into food, beverage, and pharma excipient catalogs.
Typical supplier categories
- Large-scale chemical producers: produce benzoic acid and neutralize to sodium benzoate for commodity markets.
- Excipient manufacturers: supply to pharma customers with spec sheets aligned to USP/NF expectations.
- Distributors and re-packagers: supply in lab or commercial scales with batch documentation.
Key spec gates for pharma
- USP/NF compliance status (or internal specification equivalence) and certificate language.
- Impurities: benzoic acid content vs total benzoate, related aromatic impurities, and heavy metals limits.
- Microbial and endotoxin statements (if required by the finished dosage form).
- Stability and storage conditions aligned to formulation needs.
- Particle size distribution for uniformity in liquid or semi-solid bases.
Which suppliers are most reliable for bulk sourcing of sodium phenylacetate?
Reliability in bulk sourcing depends on consistent batch quality and a documented path to pharmaceutical-grade specs. In practice, procurement teams typically choose suppliers with one or more of the following:
- long-running chemical production footprint for phenylacetate salts
- documented GMP posture for chemical intermediates or APIs
- stable lead times and predictable MOQ for the requested grade
- strong CoA-to-batch traceability practices
- ability to provide impurity disclosures and change-control notifications
Supplier selection workflow used by pharma purchasers
- Confirm required grade and standard (pharma compendial vs food vs reagent).
- Require CoA for recent batches plus full spec and analytical methods.
- Validate residual solvents, water content, and impurity profile fit.
- Assess change control and whether the supplier offers notification for source/route changes.
- Evaluate logistics and shelf-life policies for salt hygroscopicity.
Which suppliers are most reliable for bulk sourcing of sodium benzoate?
For sodium benzoate, the reliability gate is usually less about “does the supplier have the chemical” and more about consistent excipient quality and documentation.
- Choose suppliers that can provide compendial grade statements and meet pharma heavy metals and impurity limits.
- Use vendors with consistent particle size control if formulation uniformity is sensitive.
- Require endotoxin or bioburden documentation if the finished product requires it.
How do supplier choices differ by application: API-intermediate vs formulation excipient?
Sodium benzoate and sodium phenylacetate can occupy different roles depending on the finished dosage form.
- If sodium phenylacetate is used as an active drug component or critical salt: procure under the tightest quality expectations (pharma-grade with drug-quality documentation).
- If sodium benzoate is used as excipient/preservative: excipient grade suffices, with emphasis on USP/NF compliance and preservative function-related specs (impurity/assay and microbiological control).
These differences drive whether a supplier needs GMP-aligned documentation and whether audits or qualification packages are required.
What documentation should suppliers provide for pharmaceutical qualification?
For both salts, pharma qualification typically expects:
- Certificate of Analysis (CoA) per lot
- Specification sheet (assay, impurities, water content, heavy metals if applicable)
- Analytical method summaries for key parameters
- Origin and manufacturing site details
- Change control policy and notification commitments
- GMP statement aligned to the grade
- Stability and retest period statements (if provided)
For change-sensitive formulations, also request:
- impurity time-series data across multiple batches
- residual solvent analysis and water activity/hygroscopicity notes when applicable
How do you evaluate suppliers for impurity and trace-spec compliance?
Procurement teams usually assess:
- batch-to-batch variability in assay and major impurities
- presence of related aromatic impurities and any process-introduced contaminants
- heavy metals compliance for excipient use cases
- residual solvent content for grades produced through solvent routes
- moisture and physical form (critical for blending and dissolution)
What are the main supplier risk points in sodium phenylacetate and sodium benzoate sourcing?
Sodium phenylacetate
- Salt form and water content variability affecting handling and formulation uniformity.
- Impurity profile changes from process-route differences across plants.
- Potential supply volatility from smaller specialty chemical capacity.
Sodium benzoate
- Variability in excipient specs across food-grade vs pharma-grade.
- Documentation gaps (missing compendial statements or insufficient impurity panel).
- Particle size differences affecting dispersion and preservative performance in some formulations.
Competitive sourcing landscape: how many supplier options typically exist?
- Sodium benzoate: supplier options are typically numerous given broad excipient and food-market demand.
- Sodium phenylacetate: supplier options exist but are narrower than benzoate, reflecting its more specialized pharmaceutical/adjacent use profile.
Key Takeaways
- Sodium benzoate has broad, low-friction sourcing with many excipient suppliers; the key differentiator is pharma-grade documentation and spec adherence.
- Sodium phenylacetate sourcing is narrower and more quality-sensitive; salt form, water content, and impurity panels drive qualification outcomes.
- For pharmaceutical use, supplier qualification should start with grade standard confirmation (pharma compendial or internal spec) and continue with CoA review plus impurity and residual solvent fit.
FAQs
1) Are sodium phenylacetate and sodium benzoate interchangeable in formulations?
They are not interchangeable; they are different salts with different chemical properties, stability behavior, and functional roles in formulations.
2) What grade should be used for pharma products: USP/NF vs food-grade?
Use the grade that matches the finished product’s regulatory and quality requirements, typically USP/NF-aligned or pharma-grade internal specifications rather than food-grade.
3) What impurity specifications matter most for sodium phenylacetate?
Assay, water content, related aromatic impurities, and process-introduced byproducts; residual solvents and heavy metals also matter depending on regulatory expectations.
4) What documentation is typically required from excipient suppliers for sodium benzoate?
CoA per lot, spec sheet, compendial/grade statement, impurity and heavy metals compliance, and GMP/grade documentation aligned to the supplier’s manufacturing posture.
5) How do supplier changes affect stability and formulation performance?
Different lots and suppliers can shift water content, particle size, and impurity profiles, which can change dissolution, solubility behavior, and preservative/functional performance.
